Early Development Leader (EDL) @ (July 2017 - May 2022)
Senior Scientific Investigator @ (October 2009 - May 2022)
Industry Sponsor and Advisor - NC3Rs CRACK-IT 'Osteo-Chip' Challenge @ (June 2017 - September 2021)
Industry Partner - FNIH OA Biomarkers Consortium @ (January 2012 - January 2015)
Chair - Innovate UK (Technology Strategy Board) OA Stratified Medicine Consortium @ (February 2011 - February 2013)
Lead Investigator - ADM114621 Clinical Study @ (March 2010 - June 2011)
Investigator @ (October 2006 - October 2009)
Principal Scientist @ (November 2004 - October 2006)
Postdoctoral Fellow @ (January 2003 - November 2004)
Postdoctoral Scientist @ Eli Lilly & Co. (January 2000 - January 2003)
Jonathan Larkin Education
Jefferson Health
PhD (Cell Biology, Immunology)
1995-2000
Moravian University
BS (Biology)
1990-1994
Jonathan Larkin Skills
Drug Discovery
Pharmacology
Immunology
Biomarkers
In Vitro
Clinical Development
Assay Development
Translational Medicine
Molecular Biology
Monoclonal Antibodies
In Vivo
Cell Biology
Lifesciences
Inflammation
Translational Research
Cell
High Throughput Screening
Antibodies
Protein Chemistry
Drug Development
Biochemistry
Immunoassays
Vaccines
Life Sciences
Jonathan Larkin Summary
Jonathan Larkin, based in Philadelphia, PA, US, is currently a Consultant (IHI Probe) at Chondrometrics GmbH. Jonathan Larkin brings experience from previous roles at University of Oulu, Bracken, SynOA Therapeutics and GSK. Jonathan Larkin holds a 1995 - 2000 PhD in Cell Biology, Immunology @ Jefferson Health. With a robust skill set that includes Drug Discovery, Pharmacology, Immunology, Biomarkers, In Vitro and more. Jonathan Larkin has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jonathan Larkin?
Find contact details for 700 million professionals.